Skip to content

C.E Pharma

Active
Private limited companyfounded 20223 yrs activeRansfortstraat 87, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0793.409.817
Summary

The computed 12-month bankruptcy probability of C.E Pharma is 3.1% (moderate). The 2025 annual accounts show negative equity (-€46,167) and a net result of -€17,197. Equity is shrinking by ~68.8% per year across the filed fiscal years. Its solvency ranks better than 17% of 22044 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
C.E PharmaActiveChecked score 49/100
Risk analysis ReportCompare

History

On 8 November 2022, C.E Pharma was incorporated as a Private limited company.1 Total assets went from €349,028 in 2023 to €263,031 in 2025 and headcount from 0.5 to 1.1 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
31-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 31 days late
2024
31-12
Financial Weakest financial yearnet -€22,691
Net result drops to -€22,691, the lowest in the series; recovery starts the following year.
07-10
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 68 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure